ALPS Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-892,200
Closed -$8.64M 1118
2025
Q2
$8.64M Sell
892,200
-6,354
-0.7% -$65.5K 0.05% 180
2025
Q1
$13.4M Buy
898,554
+64,670
+8% +$995K 0.08% 143
2024
Q4
$12.4M Buy
833,884
+127,089
+18% +$2.07M 0.08% 149
2024
Q3
$13.5M Buy
706,795
+134,869
+24% +$2.8M 0.09% 139
2024
Q2
$11.8M Buy
571,926
+78,399
+16% +$1.56M 0.08% 133
2024
Q1
$9.28M Buy
493,527
+74,530
+18% +$1.28M 0.07% 159
2023
Q4
$6.04M Sell
418,997
-1,110,589
-73% -$15.1M 0.05% 197
2023
Q3
$26.6M Buy
1,529,586
+164,099
+12% +$3.42M 0.22% 48
2023
Q2
$28.4M Buy
1,365,487
+155,625
+13% +$3.38M 0.25% 44
2023
Q1
$28.5M Buy
1,209,862
+158,515
+15% +$4.26M 0.25% 55
2022
Q4
$29.4M Buy
1,051,347
+943,047
+871% +$24.1M 0.26% 45
2022
Q3
$2.53M Buy
+108,300
New +$3.27M 0.02% 259

Other funds holding OGN

ALPS Advisors's OGN Position: Q3 2025 in Review

ALPS Advisors sold out of Organon & Co (OGN) in Q3 2025, closing a stake of 892,200 shares — an estimated $8.64M sold.

ALPS Advisors first reported a position in OGN in Q3 2022 and held it in 12 quarters. The position peaked at $29.4M in Q4 2022. 669 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

  • ALPS Advisors reported no remaining Organon & Co position as of Q3 2025 after selling out during the quarter.
  • ALPS Advisors sold 892,200 Organon & Co shares in Q3 2025, an estimated $8.64M.
  • ALPS Advisors first reported a position in Organon & Co in Q3 2022 and held it in 12 quarters.
  • ALPS Advisors's Organon & Co position peaked at $29.4M in Q4 2022.
  • 669 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on ALPS Advisors's 13F filing for Q3 2025, filed 5 Nov 2025.